Trustees of Princeton University’s Audentes Therapeutics, Inc BOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-27,522
Closed -$1.65M 9
2019
Q4
$1.65M Buy
+27,522
New +$1.03M 1.29% 6
2019
Q2
Sell
-19,951
Closed -$778K 4
2019
Q1
$778K Buy
+19,951
New +$572K 0.99% 4

Trustees of Princeton University's BOLD Position: Q1 2020 in Review

Trustees of Princeton University sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 27,522 shares — an estimated $1.65M sold.

Trustees of Princeton University first reported a position in BOLD in Q1 2019 and held it in 2 quarters. The position peaked at $1.65M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Trustees of Princeton University reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Trustees of Princeton University sold 27,522 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $1.65M.
  • Trustees of Princeton University first reported a position in Audentes Therapeutics, Inc in Q1 2019 and held it in 2 quarters.
  • Trustees of Princeton University's Audentes Therapeutics, Inc position peaked at $1.65M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Trustees of Princeton University's 13F filing for Q1 2020, filed 8 May 2020.